Forsta AP Fonden lessened its holdings in Danaher Corporation (NYSE:DHR) by 20.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 424,958 shares of the conglomerate’s stock after selling 106,266 shares during the quarter. Danaher Corporation accounts for approximately 1.3% of Forsta AP Fonden’s holdings, making the stock its 22nd biggest holding. Forsta AP Fonden owned approximately 0.06% of Danaher Corporation worth $36,453,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. GQG Partners LLC bought a new stake in Danaher Corporation in the 2nd quarter valued at $101,000. Proficio Capital Partners LLC increased its holdings in Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares during the period. Monetary Management Group Inc. increased its holdings in Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after buying an additional 150 shares during the period. Acrospire Investment Management LLC increased its holdings in Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after buying an additional 1,100 shares during the period. Finally, ClariVest Asset Management LLC bought a new stake in Danaher Corporation in the 1st quarter valued at $157,000. 75.38% of the stock is currently owned by hedge funds and other institutional investors.

In other Danaher Corporation news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the company’s stock in a transaction dated Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the transaction, the chief executive officer now owns 271,737 shares in the company, valued at $25,173,715.68. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 317,498 shares of company stock worth $28,838,801. Corporate insiders own 12.20% of the company’s stock.

Several brokerages have issued reports on DHR. Goldman Sachs Group, Inc. (The) reissued a “neutral” rating and issued a $83.00 price target on shares of Danaher Corporation in a report on Tuesday, September 26th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a report on Tuesday, August 1st. Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. Finally, Robert W. Baird upped their target price on shares of Danaher Corporation from $87.00 to $97.00 and gave the stock an “outperform” rating in a report on Friday, October 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $93.31.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/11/19/forsta-ap-fonden-has-36-45-million-holdings-in-danaher-corporation-dhr.html.

Danaher Corporation (NYSE:DHR) opened at $93.30 on Friday. The stock has a market cap of $64,899.95, a PE ratio of 23.98, a P/E/G ratio of 2.22 and a beta of 1.02. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $93.86.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.87 EPS. analysts forecast that Danaher Corporation will post 3.99 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. Danaher Corporation’s payout ratio is presently 16.52%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.